Clinical Trial Update: A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tacrolimus in combination with corticosteroid therapy for Minimal Change Nephrotic Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Change Nephrotic Syndrome

Drugs mentioned

• Corticosteroid (corticosteroid)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: MCNS, Minimal Change Nephrotic Syndrome (MCNS) | Phase 4 | Status: COMPLETED